[{
        "id": 1,
        "status": "not-checked",
        "related": true,
        "badges": [
            "misleading",
            "health"
        ],
        "text": "The COVID-19 vaccine developed by Pfizer-BioNTech has an efficacy rate of 95% in preventing symptomatic COVID-19 infections.",
        "metadata": {
            "author": "Dr. Jennifer Thompson",
            "source": "The Economist",
            "date": "09.05.2024"
        }
    },
    {
        "id": 2,
        "status": "not-checked",
        "related": true,
        "badges": [
            "misleading",
            "health"
        ],
        "text": "The COVID-19 vaccine developed by Pfizer-BioNTech has an efficacy rate of 95% in preventing symptomatic COVID-19 infections.",
        "metadata": {
            "author": "Dr. Jennifer Thompson",
            "source": "The Economist",
            "date": "09.05.2024"
        }
    },
    {
        "id": 3,
        "status": "not-checked",
        "related": true,
        "badges": [
            "misleading",
            "health"
        ],
        "text": "The COVID-19 vaccine developed by Pfizer-BioNTech has an efficacy rate of 95% in preventing symptomatic COVID-19 infections.",
        "metadata": {
            "author": "Dr. Jennifer Thompson",
            "source": "The Economist",
            "date": "09.05.2024"
        }
    }
]